(5- (4- amino- 6- bromo- 5- carbamoyl- 1H- pyrrolo(2,3- d)pyrimidin- 1- yl)- 3,4- dihydroxytetrahydrofuran- 2- yl)methyl isobutyrate
ibutocydine is the (2S,3S,4S,5S)-isomer; prodrug of BMK-Y101; antineoplastic agent that inhibits both Cdk7 and Cdk9; structure in first source
Also Known As:
ibulocydine
Networked: 3
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Kim, B Moon:
3 articles
(01/2017 - 06/2011)
|
2. | Cho, Dong-Hyung:
2 articles
(01/2017 - 08/2014)
|
3. | Choi, Eun Kyung:
2 articles
(01/2017 - 08/2014)
|
4. | Hwang, Jung Jin:
2 articles
(01/2017 - 08/2014)
|
5. | Jeong, Seong-Yun:
2 articles
(01/2017 - 08/2014)
|
6. | Ju, Eun Jin:
2 articles
(01/2017 - 08/2014)
|
7. | Lee, Jung Shin:
2 articles
(01/2017 - 08/2014)
|
8. | Park, Seok Soon:
2 articles
(01/2017 - 08/2014)
|
9. | Shin, Seol Hwa:
2 articles
(01/2017 - 08/2014)
|
10. | Song, Si Yeol:
2 articles
(01/2017 - 08/2014)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures